Log in to save to my catalogue

Validation of T-Track® CMV to assess the functionality of cytomegalovirus-reactive cell-mediated imm...

Validation of T-Track® CMV to assess the functionality of cytomegalovirus-reactive cell-mediated imm...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5339958

Validation of T-Track® CMV to assess the functionality of cytomegalovirus-reactive cell-mediated immunity in hemodialysis patients

About this item

Full title

Validation of T-Track® CMV to assess the functionality of cytomegalovirus-reactive cell-mediated immunity in hemodialysis patients

Publisher

England: BioMed Central

Journal title

BMC immunology, 2017-03, Vol.18 (1), p.15-15, Article 15

Language

English

Formats

Publication information

Publisher

England: BioMed Central

More information

Scope and Contents

Contents

Uncontrolled cytomegalovirus (CMV) replication in immunocompromised solid-organ transplant recipients is a clinically relevant issue and an indication of impaired CMV-specific cell-mediated immunity (CMI). Primary aim of this study was to assess the suitability of the immune monitoring tool T-Track® CMV to determine CMV-reactive CMI in a cohort of...

Alternative Titles

Full title

Validation of T-Track® CMV to assess the functionality of cytomegalovirus-reactive cell-mediated immunity in hemodialysis patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5339958

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5339958

Other Identifiers

ISSN

1471-2172

E-ISSN

1471-2172

DOI

10.1186/s12865-017-0194-z

How to access this item